inmunebio.jpg
INmune Bio, Inc. to Present at the BIO CEO & Investor Conference
08 févr. 2022 09h00 HE | INmune Bio, Inc.
BOCA RATON, Florida., Feb. 08, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...
Logo.png
INmune Bio, Inc. Announces Pricing of Initial Public Offering
15 janv. 2019 15h00 HE | INmune Bio, Inc.
LA JOLLA, CA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (“INmune” or the “Company”), an immunotherapy company focused on developing therapies that harness the patient’s innate immune...